NCT05558007 - Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 22, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

January 31, 2025

Conditions

Erectile Dysfunction Following Radical ProstatectomyErectile DysfunctionProstate CancerRadical Prostatectomy

Interventions

DRUG

Tadalafil 5mg

Daily oral administration of tadalafil 5mg

DRUG

BZ371A

Topical application of 1.5 mL of BZ371A in a concentration of 5mg/mL

DRUG

Oral Placebo

Oral administration of a placebo pill

DRUG

Topical Placebo

Topical application of 1.5 mL of placebo

Trial Locations (1)

RECRUITING

Hospital Urológica, Belo Horizonte